FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4319982925> ?p ?o ?g. }

• W4319982925 endingPage "1125" @default.
• W4319982925 startingPage "1125" @default.
• W4319982925 abstract "Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a novel intraperitoneal drug delivery method of low-dose chemotherapy as a pressurized aerosol in patients affected by peritoneal cancer of primary or secondary origin. We performed a systematic review and meta-analysis with the aim of assessing the feasibility, safety, and efficacy of PIPAC.A systematic literature search was performed using Medline and Web of Science databases from 1 January 2011, to inception, to 31 December 2021. Data were independently extracted by two authors. The Newcastle-Ottawa Scale was used to assess the quality and risk of bias of studies. Meta-analysis was performed for pathological response, radiological response, PCI variation along treatment, and for patients undergoing three or more PIPAC. Pooled analyses were performed using the Freeman-Tukey double arcsine transformation, and 95% CIs were calculated using Clopper-Pearson exact CIs in all instances.A total of 414 papers on PIPAC were identified, and 53 studies considering 4719 PIPAC procedure in 1990 patients were included for analysis. The non-access rate or inability to perform PIPAC pooled rate was 4% of the procedures performed. The overall proportion of patients who completed 3 or more cycles of PIPAC was 39%. Severe toxicities considering CTCAE 3-4 were 4% (0% to 38.5%). In total, 50 studies evaluated deaths within the first 30 postoperative days. In the included 1936 patients were registered 26 deaths (1.3%). The pooled analysis of all the studies reporting a pathological response was 68% (95% CI 0.61-0.73), with an acceptable heterogeneity (I2 28.41%, p = 0.09). In total, 10 papers reported data regarding the radiological response, with high heterogeneity and a weighted means of 15% (0% to 77.8%). PCI variation along PIPAC cycles were reported in 14 studies. PCI diminished, increased, or remained stable in eight, one and five studies, respectively, with high heterogeneity at pooled analysis. Regarding survival, there was high heterogeneity. The 12-month estimated survival from first PIPAC for colorectal cancer, gastric cancer, gynecological cancer and hepatobiliary/pancreatic cancer were, respectively, 53%, 25%, 59% and 37%.PIPAC may be a useful treatment option for selected patients with PM, with acceptable grade 3 and 4 toxicity and promising survival benefit. Meta-analysis showed high heterogeneity of data among up-to-date available studies. In a subset analysis per primary tumor origin, pathological tumor regression was documented in 68% of the studies with acceptable heterogeneity. Pathological regression seems, therefore, a reliable outcome for PIPAC activity and a potential surrogate endpoint of treatment response. We recommend uniform selection criteria for patients entering a PIPAC program and highlight the urgent need to standardize items for PIPAC reports and datasets." @default.
• W4319982925 created "2023-02-11" @default.
• W4319982925 creator A5000370135 @default.
• W4319982925 creator A5008378806 @default.
• W4319982925 creator A5011430011 @default.
• W4319982925 creator A5013212176 @default.
• W4319982925 creator A5017714141 @default.
• W4319982925 creator A5030983004 @default.
• W4319982925 creator A5034048815 @default.
• W4319982925 creator A5034550586 @default.
• W4319982925 creator A5044013265 @default.
• W4319982925 creator A5051961211 @default.
• W4319982925 creator A5061963182 @default.
• W4319982925 creator A5065415636 @default.
• W4319982925 creator A5065431761 @default.
• W4319982925 creator A5067200921 @default.
• W4319982925 creator A5074328151 @default.
• W4319982925 date "2023-02-09" @default.
• W4319982925 modified "2023-10-14" @default.
• W4319982925 title "10 Years of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): A Systematic Review and Meta-Analysis" @default.
• W4319982925 cites W1853593785 @default.
• W4319982925 cites W2051099595 @default.
• W4319982925 cites W2060590865 @default.
• W4319982925 cites W2117190139 @default.
• W4319982925 cites W2161579588 @default.
• W4319982925 cites W2170008162 @default.
• W4319982925 cites W2170928115 @default.
• W4319982925 cites W2287798134 @default.
• W4319982925 cites W2344894825 @default.
• W4319982925 cites W2521892896 @default.
• W4319982925 cites W2524247262 @default.
• W4319982925 cites W2531203326 @default.
• W4319982925 cites W2590370975 @default.
• W4319982925 cites W2591361541 @default.
• W4319982925 cites W2605936377 @default.
• W4319982925 cites W2609897303 @default.
• W4319982925 cites W2615552839 @default.
• W4319982925 cites W2751148579 @default.
• W4319982925 cites W2760472470 @default.
• W4319982925 cites W2766777872 @default.
• W4319982925 cites W2779060665 @default.
• W4319982925 cites W2799675510 @default.
• W4319982925 cites W2803251990 @default.
• W4319982925 cites W2803539671 @default.
• W4319982925 cites W2806804067 @default.
• W4319982925 cites W2885546665 @default.
• W4319982925 cites W2898330049 @default.
• W4319982925 cites W2902772726 @default.
• W4319982925 cites W2905254350 @default.
• W4319982925 cites W2908564518 @default.
• W4319982925 cites W2922610560 @default.
• W4319982925 cites W2944802824 @default.
• W4319982925 cites W2946079442 @default.
• W4319982925 cites W2950495184 @default.
• W4319982925 cites W2952059318 @default.
• W4319982925 cites W2954661925 @default.
• W4319982925 cites W2970616636 @default.
• W4319982925 cites W2970652035 @default.
• W4319982925 cites W3004076032 @default.
• W4319982925 cites W3005721967 @default.
• W4319982925 cites W3011836017 @default.
• W4319982925 cites W3022724148 @default.
• W4319982925 cites W3023078202 @default.
• W4319982925 cites W3032127684 @default.
• W4319982925 cites W3033123563 @default.
• W4319982925 cites W3034979142 @default.
• W4319982925 cites W3035883604 @default.
• W4319982925 cites W3045316564 @default.
• W4319982925 cites W3092200541 @default.
• W4319982925 cites W3097764331 @default.
• W4319982925 cites W3099536473 @default.
• W4319982925 cites W3103013210 @default.
• W4319982925 cites W3124566858 @default.
• W4319982925 cites W3127884565 @default.
• W4319982925 cites W3134293541 @default.
• W4319982925 cites W3144543375 @default.
• W4319982925 cites W3153022929 @default.
• W4319982925 cites W3159256634 @default.
• W4319982925 cites W3188439598 @default.
• W4319982925 cites W3193666836 @default.
• W4319982925 cites W3202780245 @default.
• W4319982925 cites W3207770793 @default.
• W4319982925 cites W3211528296 @default.
• W4319982925 cites W4214948550 @default.
• W4319982925 cites W4233339294 @default.
• W4319982925 cites W4248265664 @default.
• W4319982925 cites W4281397128 @default.
• W4319982925 cites W4282946931 @default.
• W4319982925 cites W4285586309 @default.
• W4319982925 cites W4319982925 @default.
• W4319982925 cites W2955298075 @default.
• W4319982925 doi "https://doi.org/10.3390/cancers15041125" @default.
• W4319982925 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36831468" @default.
• W4319982925 hasPublicationYear "2023" @default.
• W4319982925 type Work @default.
• W4319982925 citedByCount "1" @default.
• W4319982925 countsByYear W43199829252023 @default.
• W4319982925 crossrefType "journal-article" @default.

• next